RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
110 hedge funds and large institutions have $854M invested in Revance Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
11% less capital invested
Capital invested by funds: $957M → $854M (-$103M)
Holders
110
Holding in Top 10
2
Calls
$2.08M
Puts
$1.94M
Top Buyers
| 1 | +$12.9M | |
| 2 | +$10.9M | |
| 3 | +$8.5M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$8.08M |
| 5 |
BlackRock
New York
|
+$6.54M |
Top Sellers
| 1 | -$27.3M | |
| 2 | -$16M | |
| 3 | -$11.3M | |
| 4 |
O
OppenheimerFunds
New York
|
-$6.93M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$5.22M |